Previously, we have demonstrated that dexamethasone-resistant B-cell acute lymphoblastic leukemia cells that express the oncogenic mutant of FLT3 display upregulation of AXL expression upon inhibition of FLT3 [44]. Here, FLT3 is linked to B-cell acute lymphoblastic leukemia.